BioSyent, Inc. (RX.V)
17.79
-0.21
(-1.17%)
CAD |
TSXV |
Nov 13, 16:00
BioSyent Market Cap : 201.74M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 201.74M |
| November 12, 2026 | 204.13M |
| November 11, 2026 | 205.26M |
| November 10, 2026 | 202.99M |
| November 09, 2026 | 202.99M |
| November 06, 2026 | 200.72M |
| November 05, 2026 | 196.64M |
| November 04, 2026 | 194.49M |
| November 03, 2026 | 191.08M |
| November 02, 2026 | 193.35M |
| October 30, 2026 | 193.81M |
| October 29, 2026 | 190.86M |
| October 28, 2026 | 192.79M |
| October 27, 2026 | 189.27M |
| October 26, 2026 | 188.36M |
| October 23, 2026 | 192.22M |
| October 22, 2026 | 192.22M |
| October 21, 2026 | 193.58M |
| October 20, 2026 | 192.33M |
| October 19, 2026 | 190.40M |
| October 16, 2026 | 189.72M |
| October 15, 2026 | 181.67M |
| October 14, 2026 | 180.20M |
| October 13, 2026 | 181.10M |
| October 09, 2026 | 194.49M |
| Date | Value |
|---|---|
| October 08, 2026 | 191.88M |
| October 07, 2026 | 191.65M |
| October 06, 2026 | 190.52M |
| October 05, 2026 | 191.20M |
| October 02, 2026 | 189.72M |
| October 01, 2026 | 187.12M |
| September 30, 2026 | 189.38M |
| September 29, 2026 | 190.29M |
| September 28, 2026 | 190.29M |
| September 25, 2026 | 183.71M |
| September 24, 2026 | 187.68M |
| September 23, 2026 | 187.57M |
| September 22, 2026 | 198.34M |
| September 21, 2026 | 181.44M |
| September 18, 2026 | 178.38M |
| September 17, 2026 | 182.13M |
| September 16, 2026 | 182.35M |
| September 15, 2026 | 181.22M |
| September 14, 2026 | 179.74M |
| September 11, 2026 | 177.59M |
| September 10, 2026 | 177.48M |
| September 09, 2026 | 177.93M |
| September 08, 2026 | 179.74M |
| September 04, 2026 | 181.10M |
| September 03, 2026 | 180.08M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 116.01M |
| Bausch Health Cos., Inc. | 4.457B |
| Cipher Pharmaceuticals, Inc. | 360.13M |
| Revive Therapeutics Ltd. | 6.535M |
| Knight Therapeutics, Inc. | 1.185B |
Market Cap Related Metrics
| PE Ratio | 20.75 |
| PS Ratio | 3.674 |
| PEG Ratio | 1.046 |
| Price to Book Value | 4.401 |
| Price to Free Cash Flow | 17.59 |
| Price | 17.79 |
| Earnings Yield | 4.82% |
| PEGY Ratio | 0.9861 |
| Operating PE Ratio | 15.85 |
| Normalized PE Ratio | 20.75 |